retatrutide fat loss clinical trial 🚨 BREAKING: Shows “Bariatric-Level” Weight in Phase 3 New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Eli Lilly's Phase 3 clinical

Saponaro F, Sestito S, Runfola M, Rapposelli S, Chiellini G

Standard research protocols use 0.5-1.0mg per injection, with weekly dosing typical

The News About the Semaglutide Pill In December 2025, the Food and Drug Administration approved the oral form of semaglutide, which, like the injection, mimics GLP-1 hormones to reduce appetite, slow digestion, improve blood sugar regulation and more

Britain is starting to build a health strategy on medicines whose price tags and supply chains sit firmly in the hands of companies overseas

Phase 3 data shows approximately 22-25% weight loss, making it competitive with retatrutide through a completely different mechanism